Cary Street Partners’s Vanguard S&P Mid-Cap 400 Growth ETF IVOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.17M Sell
8,560
-5,168
-38% -$730K 0.02% 481
2026
Q2
$2.01M Hold
13,728
– – 0.04% 362
2026
Q1
$1.72M Hold
13,728
– – 0.04% 346
2025
Q4
$1.65M Sell
13,728
-1,863
-12% -$224K 0.04% 353
2025
Q3
$1.86M Sell
15,591
-90
-0.6% -$10.5K 0.05% 331
2025
Q2
$1.77M Sell
15,681
-42,770
-73% -$4.55M 0.05% 326
2025
Q1
$6.03M Buy
58,451
+5,019
+9% +$561K 0.19% 125
2024
Q4
$6.02M Hold
53,432
– – 0.2% 117

Other funds holding IVOG

Cary Street Partners's IVOG Position: Q3 2026 in Review

Cary Street Partners reduced its Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) stake by 38% in Q3 2026, selling an estimated $730K and leaving 8,560 shares worth $1.17M. The position accounts for 0.02% of the portfolio, ranked #481.

Cary Street Partners first reported a position in IVOG in Q4 2024 and has held it in 8 quarters since. The position peaked at $6.03M in Q1 2025. 192 funds tracked by Wall St. Rank hold IVOG as of Q3 2026.

  • Cary Street Partners held 8,560 shares of Vanguard S&P Mid-Cap 400 Growth ETF worth $1.17M as of Q3 2026.
  • Cary Street Partners sold 5,168 Vanguard S&P Mid-Cap 400 Growth ETF shares in Q3 2026, an estimated $730K.
  • Vanguard S&P Mid-Cap 400 Growth ETF made up 0.02% of Cary Street Partners's portfolio in Q3 2026, its #481 holding.
  • Cary Street Partners first reported a position in Vanguard S&P Mid-Cap 400 Growth ETF in Q4 2024 and has held it in 8 quarters since.
  • Cary Street Partners's Vanguard S&P Mid-Cap 400 Growth ETF position peaked at $6.03M in Q1 2025.
  • 192 funds tracked by Wall St. Rank held Vanguard S&P Mid-Cap 400 Growth ETF as of Q3 2026.

Based on Cary Street Partners's 13F filing for Q3 2026, filed 12 Nov 2026.